Seelos Therapeutics, Inc. (SEELQ)
OTCMKTS · Delayed Price · Currency is USD
0.0001
+0.0001 (9,900.00%)
Jan 30, 2026, 1:20 PM EST
Seelos Therapeutics Market Cap
Seelos Therapeutics has a market cap or net worth of $136 as of February 2, 2026. Its market cap has decreased by -100.00% in one year.
Market Cap
136.00
Enterprise Value
9.86M
Revenue
2.01M
Ranking
n/a
PE Ratio
0.00
Stock Price
$0.00
Market Cap Chart
Since January 24, 2019, Seelos Therapeutics's market cap has decreased from 23.95M to 136.00, a decrease of -100.00%. That is a compound annual growth rate of -82.10%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 30, 2026 | 136.00 | 13,500.00% |
| Dec 31, 2025 | 1.00 | -100.00% |
| Dec 31, 2024 | 101.27K | -99.26% |
| Dec 29, 2023 | 13.61M | -81.29% |
| Dec 30, 2022 | 72.77M | -57.68% |
| Dec 31, 2021 | 171.95M | 103.72% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jan 24, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| NanoLogix | 163.00 |
| Kiromic BioPharma | 157.00 |
| Poniard Pharmaceuticals | 150.00 |
| Q BioMed | 145.00 |
| NexImmune | 139.00 |
| PsyBio Therapeutics | 133.00 |
| Marizyme | 132.00 |
| RVL Pharmaceuticals | 111.00 |